BioCryst to Close Discovery Center, Incurring $6.2M-$7.5M in Costs

BioCryst Pharmaceuticals announced its plan to discontinue internal discovery programs and close its Discovery Center of Excellence facility in Birmingham, Alabama, as part of a strategic evolution. The company estimates one-time expenses of $6.2 million to $7.5 million for employee termination benefits and severance, with $5.3 million to $6.6 million expected as cash expenditures. Management's analysis of additional costs related to the facility closure, such as contract and lease termination or asset impairment, is still ongoing, and an estimate for these costs is not yet available.